Inotiv (NOTV) Other Accumulated Expenses (2021 - 2022)

Inotiv (NOTV) reported Other Accumulated Expenses of $3.1 million for Q2 2022, up 1850.63% quarter-over-quarter from $160000.0 in Q1 2022.

Inotiv (NOTV) Other Accumulated Expenses (2021 - 2022) Analysis & Trends

Inotiv has reported Other Accumulated Expenses for 2 years, with the latest figure at $3.1 million in Q2 2022.

For the quarter ending Q2 2022, Other Accumulated Expenses changed N/A year-over-year to $3.1 million; the trailing twelve-month figure through Jun 2022 stood at $3.1 million (changed N/A YoY), and the FY2021 full-year result was $366000.0, changed N/A from the prior year.
Other Accumulated Expenses for Q2 2022 stood at $3.1 million, up from $160000.0 in the prior quarter.
The five-year high for Other Accumulated Expenses was $8.1 million in Q4 2021, with the low at $160000.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	Inotiv	3.24 Mn	-11.94 Mn	111.99 Mn

Download Data